sarepta therapeutics nasdaq - Search News

Order byBest matchMost fresh

News

FDA asks Sarepta to stop shipping gene therapy

InvestorsHub on MSN · 3h

Sarepta Shares Drop as FDA Suspends Gene Therapy Trials for Muscular Dystrophy

Shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) plunged 10% after the company disclosed that the U.S. Food and Drug Administration (FDA) has imposed a clinical hold on several of its gene therapy programs targeting limb girdle muscular dystrophy (LGMD).

Continue reading

· 5h · on MSN

Sarepta slides as FDA places clinical hold on gene therapy clinical trials

Sarepta's Setback Deepens With Another Gene Therapy Fatality

7hon MSN

Sarepta extends losses premarket after refusing FDA’s halt request

Sarepta Therapeutics (SRPT) shares fell as much as 4.8% in premarket trading Monday, poised to extend losses for a second ...

13m

Stock market today: Dow jumps, S&P 500, Nasdaq on pace to new records to start busy week of Big Tech-dominated earnings

US stocks rose on Monday, with fresh records for the Nasdaq Composite (^IXIC) and S&P 500 (^GSPC) in sight as Wall Street ...

4d

Sarepta Therapeutics: What's Happening With SRPT Stock?

The favorable market reaction indicates investor relief at management’s swift measures to rectify the company's worsening ...

2don MSN

Sarepta to continue Elevidys shipments despite FDA request to halt

Sarepta (SRPT) plans to continue Elevidys shipments for Duchenne muscular dystrophy, despite FDA request not to do so after ...

4d

Sarepta Therapeutics Stock Is Surging After The Bell: What's Going On?

Sarepta Therapeutics Inc (NASDAQ:SRPT) shares are soaring in Wednesday’s after-hours session after the company announced a ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results